NK
Nazim Kuraisi
About Nazim Kuraisi
Data last updated:
Nazim Kuraisi is a Director at Novo Genetics Life Sciences Private Limited (since 2023) and Director at Blowfly Pharmaceutical India Private Limited (since 2019). The companies operate in Paper and Pharma. The largest current company by reported revenue is Novo Genetics Life Sciences Private Limited at ₹12.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Novo Genetics Life Sciences Private Limited U21001KA2023PTC181269 | Director | 22 Nov 2023 | 2023 | ₹12.8 Lakh (FY 2025) | Active |
| Blowfly Pharmaceutical India Private Limited U24304KA2019PTC126920 | Director | 08 Aug 2019 | 2019 | Active |
Board colleagues of Nazim Kuraisi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ritesh Singh | 10400995 | Novo Genetics Life Sciences Private Limited | Director |
| Vijay Kumar Vishwakarma | 10400996 | Novo Genetics Life Sciences Private Limited | Director |
| Nazim Sekh | 08533295 | Blowfly Pharmaceutical India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nazim Kuraisi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nazim Kuraisi
Nazim Kuraisi currently holds 2 directorships: Novo Genetics Life Sciences Private Limited (Director, since 22 Nov 2023, revenue ₹12.8 Lakh (FY 2025)); Blowfly Pharmaceutical India Private Limited (Director, since 08 Aug 2019).
Nazim Kuraisi was first appointed on 08 Aug 2019 as Director at Blowfly Pharmaceutical India Private Limited. The most recent appointment on record is 22 Nov 2023 at Novo Genetics Life Sciences Private Limited.
The current boards of Nazim Kuraisi's companies include Ritesh Singh (Novo Genetics Life Sciences Private Limited), Vijay Kumar Vishwakarma (Novo Genetics Life Sciences Private Limited), Nazim Sekh (Blowfly Pharmaceutical India Private Limited).